These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38636128)
1. Development of benzimidazole-based compounds as novel capsid assembly modulators for the treatment of HBV infection. Du K; Wang X; Bai Y; Zhang X; Xue J; Li S; Xie Y; Sang Z; Tang Y; Wang X Eur J Med Chem; 2024 May; 271():116402. PubMed ID: 38636128 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and anti-HBV activity study of novel HBV capsid assembly modulators. Liang M; Liu L; Liu J; Yang Z; Wang M; Xie Y; Cai Y; Xue P; Chen Y; Zhan P; Jia H Bioorg Med Chem Lett; 2024 Nov; 112():129913. PubMed ID: 39111727 [TBL] [Abstract][Full Text] [Related]
3. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus. Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799 [TBL] [Abstract][Full Text] [Related]
4. Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays. Wang Y; Wang Z; Liu J; Wang Y; Wu R; Sheng R; Hou T Bioorg Med Chem; 2021 Apr; 36():116096. PubMed ID: 33721800 [TBL] [Abstract][Full Text] [Related]
5. A new series of HAPs as anti-HBV agents targeting at capsid assembly. Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104 [TBL] [Abstract][Full Text] [Related]
6. Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379. Berke JM; Dehertogh P; Vergauwen K; Mostmans W; Vandyck K; Raboisson P; Pauwels F Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094138 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus. Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W Bioorg Med Chem; 2010 Jul; 18(14):5048-55. PubMed ID: 20639110 [TBL] [Abstract][Full Text] [Related]
8. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus. Berke JM; Dehertogh P; Vergauwen K; Van Damme E; Mostmans W; Vandyck K; Pauwels F Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584155 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives. Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators. Wang M; Zhang J; Dou Y; Liang M; Xie Y; Xue P; Liu L; Li C; Wang Y; Tao F; Zhang X; Hu H; Feng K; Zhang L; Wu Z; Chen Y; Zhan P; Jia H J Med Chem; 2023 Oct; 66(20):13968-13990. PubMed ID: 37839070 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators. Wang S; Ren Y; Li Q; Wang Y; Jiang X; Xu S; Zhang X; Zhao S; Bradley DP; Woodson ME; Zhao F; Wu S; Li Y; Tian Y; Liu X; Tavis JE; Zhan P Bioorg Chem; 2022 Dec; 129():106192. PubMed ID: 36265355 [TBL] [Abstract][Full Text] [Related]
12. Rational Design, Synthesis, and Structure-Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836. Cole AG; Kultgen SG; Mani N; Fan KY; Ardzinski A; Stever K; Dorsey BD; Mesaros EF; Thi EP; Graves I; Tang S; Harasym TO; Lee ACH; Olland A; Suto RK; Sofia MJ J Med Chem; 2024 Sep; 67(18):16773-16795. PubMed ID: 39231272 [TBL] [Abstract][Full Text] [Related]
13. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation. Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113 [TBL] [Abstract][Full Text] [Related]
14. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors. Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and anti-HBV activity of NVR3-778 derivatives. Lv K; Wu S; Li W; Geng Y; Wu M; Zhou J; Li Y; Gao Q; Liu M Bioorg Chem; 2020 Jan; 94():103363. PubMed ID: 31669092 [TBL] [Abstract][Full Text] [Related]
16. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle. Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives. Li YF; Wang GF; He PL; Huang WG; Zhu FH; Gao HY; Tang W; Luo Y; Feng CL; Shi LP; Ren YD; Lu W; Zuo JP J Med Chem; 2006 Jul; 49(15):4790-4. PubMed ID: 16854087 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV). Vandyck K; Rombouts G; Stoops B; Tahri A; Vos A; Verschueren W; Wu Y; Yang J; Hou F; Huang B; Vergauwen K; Dehertogh P; Berke JM; Raboisson P J Med Chem; 2018 Jul; 61(14):6247-6260. PubMed ID: 29906396 [TBL] [Abstract][Full Text] [Related]
20. A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection. Ko C; Bester R; Zhou X; Xu Z; Blossey C; Sacherl J; Vondran FWR; Gao L; Protzer U Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]